About АМЕЛІВУ

АМЕЛІВУ is a prescription medication containing the active ingredient Ranibizumab, a recombinant humanized monoclonal antibody fragment. It is used to treat certain eye conditions, including neovascular (wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion.

Key Benefits & Uses

Treatment of neovascular (wet) age-related macular degeneration (AMD)
Treatment of macular edema following retinal vein occlusion

Active Ingredient & Action

Ranibizumab works by binding to and inhibiting the activity of vascular endothelial growth factor A (VEGF-A), a protein involved in the formation of new blood vessels. By inhibiting VEGF-A, Ranibizumab reduces the growth of new blood vessels in the eye, which can help to slow the progression of vision loss in patients with neovascular AMD and macular edema.

Important Notes

АМЕЛІВУ is available by prescription only and should be used under the guidance of a qualified healthcare professional. Patients should be aware of the potential risks and side effects associated with this medication, including eye inflammation, increased intraocular pressure, and endophthalmitis. It is essential to follow the recommended dosing schedule and attend regular follow-up appointments with your eye doctor to monitor the effectiveness of treatment and detect any potential complications.